Current status and progress of the treatment of acute promyelocytic leukemia / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
; (12): 546-549, 2019.
Article
in Chinese
| WPRIM (Western Pacific)
| ID: wpr-751441
Responsible library:
WPRO
ABSTRACT
Acute promyelocytic leukemia (APL) is a special type of acute leukemia. The cure rate of APL has been significantly improved in the past decades due to the use of anthracyclines, all-trans retinoic acid and arsenic. Modern stratified treatment of APL further enhances the therapeutic efficacy and reduces the treatment-related toxicity. This article reviews the history of all-trans retinoic acid and arsenic into clinical application, and the characteristics of disease, treatment status of all-trans retinoic acid and arsenic, treatment mechanism and drug resistance mechanism in APL are introduced.
Full text:
Available
Database:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Journal of Leukemia & Lymphoma
Year:
2019
Document type:
Article